In a series of studies in humans and mice, the US researchers found that when L-carnitine is consumed, the bacteria in the human gut produces a compound called Trimethylamine-N-oxide, or TMAO
At the 12-month follow-up : 87.5% of patients reported significant relief defined as 50% reduction in baseline pain scores Mean VAS pain score dropped from 7.2 at baseline to 2.8 at 12 months KOOS (Knee Injury and Osteoarthritis Outcome Score) improved across all subscales: pain, symptoms, activities of daily living, sport/recreation, and quality of life No serious adverse events were reported across the treatment period The durability of the response at 12 months is particularly notable
Clinically, GLP-1s show potential beyond diabetes and obesitythere's promise in areas like sleep apnea and cardiovascular conditions, he explained
Ask what diagnosis is being treated, what evidence supports the option, whether imaging or rehabilitation is needed, whether the source is legitimate, what risks apply to your health history, how progress will be measured, and what the plan is if symptoms do not improve
One of the two patients who discontinued liraglutide experienced an asthma exacerbation shortly after discontinuation of the GLP-1RA, whereas none of the 7 patients on liraglutide had clinical deterioration in their asthma [35]
